其他
Dermata Therapeutics(DRMA)03-04 19:05
$Dermata Therapeutics(DRMA)$ PRE 14A Other preliminary proxy statements Accession Number: 0001654954-24-002511 Act: 34 Size: 747 KB 网页链接
简介：Dermata Therapeutics, Inc.于2014年12月在特拉华州。他们是一家临床阶段的医学皮肤病学公司，专注于识别、开发和商业化用于治疗医学和美学皮肤病和病症的创新药物候选产品，他们认为由于目前的疗法不足或不存在，他们认为代表了重要的市场机会。
| 今开：0.341 | 昨收：0.3401 |
| 最高：0.3583 | 最低：0.3325 |
| 涨停价： | 跌停价： |
| 总市值：2214729 |
Dermata Therapeutics(DRMA)03-04 19:05
$Dermata Therapeutics(DRMA)$ PRE 14A Other preliminary proxy statements Accession Number: 0001654954-24-002511 Act: 34 Size: 747 KB 网页链接
Dermata Therapeutics(DRMA)03-27 04:45
$Dermata Therapeutics(DRMA)$ ARS Annual Report to Security Holders Accession Number: 0001654954-24-003661 Act: 34 Size: 113 MB 网页链接
Dermata Therapeutics(DRMA)03-22 04:15
$Dermata Therapeutics(DRMA)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001654954-24-003500 Act: 34 Size: 238 KB 网页链接
Dermata Therapeutics(DRMA)03-22 04:15
$Dermata Therapeutics(DRMA)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001654954-24-003501 Act: 34 Size: 5 MB 网页链接
Dermata Therapeutics(DRMA)03-27 04:35
$Dermata Therapeutics(DRMA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001654954-24-003658 Act: 34 Size: 33 KB 网页链接
Dermata Therapeutics(DRMA)02-15 04:45
$Dermata Therapeutics(DRMA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-001340 Act: 34 Size: 90 KB 网页链接
Dermata Therapeutics(DRMA)03-27 04:35
$Dermata Therapeutics(DRMA)$ DEF 14A Other definitive proxy statements Accession Number: 0001654954-24-003656 Act: 34 Size: 756 KB 网页链接
Qiuhaidao01-05 16:58
盘后小仓位做空DRMA查看全文
SeekingBiotech2023-04-20 21:55
DRMA received a positive response from the FDA, indicating that its documentation of CMC procedures and controls is sufficient to begin Phase 3 studies for its acne treatment, DMT310. The company plans to initiate the Phase 3 program in the second half of 2023$Dermata Therape...查看全文
牛唐2022-11-01 22:29
$Dermata Therapeutics(DRMA)$ 又一个近30%的收益。$拼多多(PDD)$ $小鹏汽车(XPEV)$查看全文
冷枪手假亦真2021-11-04 00:13
$Dermata Therapeutics(DRMA)$ 6.3加一点仓查看全文
冷枪手假亦真2021-11-03 23:27
$Dermata Therapeutics(DRMA)$ 观察仓…..先买查看全文
$Dermata Therapeutics(DRMA)$ ARS Annual Report to Security Holders Accession Number: 0001654954-24-003661 Act: 34 Size: 113 MB 网页链接
$Dermata Therapeutics(DRMA)$ DEF 14A Other definitive proxy statements Accession Number: 0001654954-24-003656 Act: 34 Size: 756 KB 网页链接
$Dermata Therapeutics(DRMA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001654954-24-003658 Act: 34 Size: 33 KB 网页链接
$Dermata Therapeutics(DRMA)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001654954-24-003500 Act: 34 Size: 238 KB 网页链接
$Dermata Therapeutics(DRMA)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001654954-24-003501 Act: 34 Size: 5 MB 网页链接
$Dermata Therapeutics(DRMA)$ PRE 14A Other preliminary proxy statements Accession Number: 0001654954-24-002511 Act: 34 Size: 747 KB 网页链接
$Dermata Therapeutics(DRMA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-001340 Act: 34 Size: 90 KB 网页链接
$Dermata Therapeutics(DRMA)$ 8-K Current report, item 5.07 Accession Number: 0001654954-24-000520 Act: 34 Size: 183 KB 网页链接
$Dermata Therapeutics(DRMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001654954-24-000296 Size: 4 KB 网页链接
$Dermata Therapeutics(DRMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001654954-24-000297 Size: 4 KB 网页链接